Worth Watching: Sunshine Heart Inc Stock Decreased as Institutional Investors Exit

November 17, 2016 - By Vivian Park   ·   0 Comments

Worth Watching: Sunshine Heart Inc Stock Decreased as Institutional Investors Exit

Sentiment for Sunshine Heart Inc (NASDAQ:SSH)

Sunshine Heart Inc (NASDAQ:SSH) institutional sentiment is 0.54 in 2016 Q2. Its the same as in 2016Q1. The ratio is neither negative nor positive, as only 7 investment managers increased or started new holdings, while 13 sold and decreased their stakes in Sunshine Heart Inc. The investment managers in our partner’s database now hold: 1.15 million shares, down from 1.25 million shares in 2016Q1. Also, the number of investment managers holding Sunshine Heart Inc in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 4 Reduced: 9 Increased: 4 New Position: 3.

About 52,089 shares traded hands. Sunshine Heart Inc (NASDAQ:SSH) has declined 75.68% since April 15, 2016 and is downtrending. It has underperformed by 80.30% the S&P500.

According to Zacks Investment Research, “Sunshine Heart, Inc. is a medical device company engaged in the commercialization of the C-Pulse Heart Assist System, an implantable, non-blood contacting, heart assist therapy for the treatment of moderate to severe heart failure. Sunshine Heart, Inc. is headquartered in Minneapolis.”

Benchmark Capital Advisors holds 0.04% of its portfolio in Sunshine Heart Inc for 98,500 shares. Bank Of America Corp De owns 2,943 shares or 0% of their US portfolio. Moreover, Blackrock Fund Advisors has 0% invested in the company for 21,729 shares. The New York-based Citigroup Inc has invested 0% in the stock. Creative Planning, a Kansas-based fund reported 2,000 shares.#img1#

Sunshine Heart Inc (NASDAQ:SSH) Ratings Coverage

Ratings analysis reveals 33% of Sunshine Heart’s analysts are positive. Out of 3 Wall Street analysts rating Sunshine Heart, 1 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $9 while the high is $10. The stock’s average target of $9 is 4984.75% above today’s ($0.177) share price. SSH was included in 6 notes of analysts from August 5, 2015. The stock of Sunshine Heart Inc (NASDAQ:SSH) has “Hold” rating given on Friday, September 4 by Zacks. The stock of Sunshine Heart Inc (NASDAQ:SSH) has “Outperform” rating given on Tuesday, November 10 by Oppenheimer. The rating was maintained by Canaccord Genuity on Tuesday, September 1 with “Buy”. The firm has “Outperform” rating given on Wednesday, August 5 by Oppenheimer. The company was downgraded on Saturday, August 29 by Zacks.

SSH Company Profile

Sunshine Heart, Inc., incorporated on August 22, 2002, is a medical device company. The Firm operates through cardiac and coronary disease products segment. The Firm is focused on developing, manufacturing and commercializing its C-Pulse Heart Assist System (the C-Pulse System) for treatment of Class III and ambulatory Class IV heart failure.

More notable recent Sunshine Heart Inc (NASDAQ:SSH) news were published by: Seekingalpha.com which released: “Can Sunshine Heart Survive To See The Dawn?” on February 27, 2016, also Seekingalpha.com with their article: “Sunshine Heart Inc.: A Sleeping Giant” published on August 23, 2013, Tcbmag.com published: “Sunshine Heart Raises $3.8 Million” on November 02, 2016. More interesting news about Sunshine Heart Inc (NASDAQ:SSH) were released by: Seekingalpha.com and their article: “Sunshine Heart – A Speculative Biotech Play For Substantial Short-Term Gains” published on January 14, 2016 as well as Globenewswire.com‘s news article titled: “Sunshine Heart Announces Clinical Update and Product Development Strategy” with publication date: July 11, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Vivian Park

Readers Comments (0)

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News